0.76%| Prev Close: | 1.78 |
|---|---|
| Open: | 1.90 |
| Bid: | 1.79 |
| Ask: | 1.88 |
| 1y Target Est: | 2.50 |
| Beta: | N/A |
| Next Earnings Date: | N/A |
| Day's Range: | 1.90 - 1.90 |
|---|---|
| 52wk Range: | 1.56 - 6.50 |
| Volume: | 295 |
| Avg Vol (3m): | 5,523 |
| Market Cap: | 16.62M |
| P/E (ttm): | N/A |
| EPS (ttm): | N/A |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in CAD.
Headlines
- Nuvo Research Announces Scientific Presentation at the Annual Meeting of the American Association of ImmunologistsCNW Group(Thu May 16)
- Nuvo Research Announces Scientific Presentation at the Annual Meeting of the American Association of ImmunologistsPR Newswire(Thu May 16)
- Nuvo Research Announces Scientific Presentation at the Annual Meeting of the American Association of ImmunologistsCNW Group(Thu May 16)
- Nuvo Research granted U.S. Patent for treatment of allergic rhinitis and allergic asthma with WF10PR Newswire(Tue May 14)
- Nuvo Research granted U.S. Patent for treatment of allergic rhinitis and allergic asthma with WF10CNW Group(Tue May 14)
- Nuvo Research granted U.S. Patent for treatment of allergic rhinitis and allergic asthma with WF10CNW Group(Tue May 14)
- Nuvo Research announces notice of Intention to Grant a European Patent for PENNSAID® 2%CNW Group(Thu May 9)
- Nuvo Research announces notice of Intention to Grant a European Patent for PENNSAID® 2%PR Newswire(Thu May 9)
- Nuvo Research announces notice of Intention to Grant a European Patent for PENNSAID® 2%CNW Group(Thu May 9)
- Nuvo Research to Complete Share ConsolidationCNW Group(Tue May 7)
- Nuvo Research to Complete Share ConsolidationPR Newswire(Tue May 7)
- Nuvo Research to Complete Share ConsolidationCNW Group(Tue May 7)
- Nuvo Research announces 2013 First Quarter ResultsCNW Group(Wed May 1)
- Nuvo Research announces 2013 First Quarter ResultsPR Newswire(Wed May 1)
- Nuvo Research announces 2013 First Quarter ResultsCNW Group(Wed May 1)
Press Releases
- Nuvo Research Announces Scientific Presentation at the Annual Meeting of the American Association of ImmunologistsCNW Group(Thu May 16)
- Nuvo Research granted U.S. Patent for treatment of allergic rhinitis and allergic asthma with WF10CNW Group(Tue May 14)
- Nuvo Research announces notice of Intention to Grant a European Patent for PENNSAID® 2%CNW Group(Thu May 9)
Must Read
- Obama's Commerce pick Pritzker faces scrutiny over ties to failed thrift, offshore tax havenThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- House approves student loan rates linked to financial markets despite a veto threatThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Loonie heads higher despite disappointing Chinese manufacturing dataThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- US new home sales rise 2.3 per cent in April while median home prices hit record highThe Canadian Press(1969-12-31T18:59:59GMT-05:00)
- Ralph Lauren's 4Q profit rises 35 pct, but posts sales shortfallThe Canadian Press(1969-12-31T18:59:59GMT-05:00)